Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Dixon Wendy L
Relationship:  
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   212,843    

Indirect Shares

   1,543      
Direct Value   $6,105,974    

Indirect Value

   $62,106      
Total Shares   214,386      
Total Value   $6,168,080      


Bristol-Myers Squibb Co $3,501,871 Incyte Corp $1,018,106 Alkermes Plc $1,233,008 Bluebird Bio, Inc. $10,652 Arvinas Holding Company, Llc $161,200 Black Diamond Therapeutics, Inc. $181,137 Bristol-Myers Squibb Co $3,501,871 Incyte Corp $1,018,106 Alkermes Plc $1,233,008 Bluebird Bio, Inc. $10,652 Arvinas Holding Company, Llc $161,200 Black Diamond Therapeutics, Inc. $181,137
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -13.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Bristol-Myers Squibb Co BMY CMO & Pres, Global Mar... 2006-05-22 87,003 2006-05-22 1,543    Premium*  
            Incyte Corp INCY Director 2022-03-31 17,768 2011-11-17 0    Premium*  
            Furiex Pharmaceuticals, Inc. FURX Director 2014-07-02 0 2013-05-24 0    Premium*  
            Alkermes Plc ALKS Director 2022-06-14 53,124 2014-03-11 0    Premium*  
            Bluebird Bio, Inc. BLUE Director 2021-11-11 11,894 2016-06-02 0    Premium*  
            Arvinas Holding Company, Llc ARVN Director 2020-06-29 5,000 0    Premium*  
            Black Diamond Therapeutics, Inc. BDTX 2024-03-15 38,054 2022-06-17 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMY Bristol-Myers Squibb Co CMO & Pres, Global Marketing   •       –      –    2006-03-07 4 A $22.73 $317,356 D/D 13,962 91,907 -
BMY Bristol-Myers Squibb Co CMO & Pres, Global Marketing   •       –      –    2006-03-07 4 D $22.73 $34,277 D/D (1,508) 90,399 -
BMY Bristol-Myers Squibb Co CMO & Pres, Global Marketing   •       –      –    2006-05-22 4 D $24.16 $82,047 D/D (3,396) 87,003 -
BMY Bristol-Myers Squibb Co CMO & Pres, Global Marketing   •       –      –    2005-03-01 4 A $0.00 $0 D/D 7,778 83,858 -
BMY Bristol-Myers Squibb Co CMO & Pres, Global Marketing   •       –      –    2005-05-20 4 D $25.64 $100,919 D/D (3,936) 79,922 -
BMY Bristol-Myers Squibb Co officerTitle   •       –      –    2005-12-02 4 D $21.69 $42,881 D/D (1,977) 77,945 -
BMY Bristol-Myers Squibb Co CMO & Pres, Global Marketing   •       –      –    2004-03-02 4 A $0.00 $0 D/D 7,556 77,556 -
BMY Bristol-Myers Squibb Co CMO & Pres, Global Marketing   •       –      –    2004-12-03 4 D $24.06 $35,513 D/D (1,476) 76,080 -
BMY Bristol-Myers Squibb Co CMO & Pres, Global Marketing   •       –      –    2003-09-10 4 A $0.00 $0 D/D 10,000 70,000 -
ALKS Alkermes Plc Director   •       •      –    2021-06-10 4 OE $18.21 $455,250 D/D 25,000 66,300 0 -
ALKS Alkermes Plc Director   •       •      –    2021-04-19 4 OE $14.60 $365,000 D/D 25,000 61,600 0 -
ALKS Alkermes Plc Director   •       •      –    2022-06-14 4 OE $0.00 $0 D/D 7,585 53,124 0 -
ALKS Alkermes Plc Director   •       •      –    2021-12-02 4 OE $0.00 $0 D/D 5,578 46,878 0 -
ALKS Alkermes Plc Director   •       •      –    2021-12-02 4 D $22.11 $29,605 D/D (1,339) 45,539 0 -
ALKS Alkermes Plc Director   •       •      –    2021-05-20 4 OE $0.00 $0 D/D 6,104 42,704 0 -
ALKS Alkermes Plc Director   •       •      –    2021-05-20 4 D $21.92 $30,776 D/D (1,404) 41,300 0 -
ALKS Alkermes Plc Director   •       •      –    2021-06-10 4 AS $25.00 $625,000 D/D (25,000) 41,300 0 %
BDTX Black Diamond Therapeutic...   –       •      –    2024-03-15 4 A $4.54 $14,769 D/D 3,253 38,054 0 -
INCY Incyte Corp Director   –       •      –    2021-12-23 4 OE $73.25 $1,465,000 D/D 20,000 37,259 0 -
ALKS Alkermes Plc Director   •       •      –    2021-01-13 4 OE $12.62 $441,700 D/D 35,000 36,600 0 -
ALKS Alkermes Plc Director   •       •      –    2021-04-19 4 AS $20.00 $500,120 D/D (25,000) 36,600 0 %
BDTX Black Diamond Therapeutic...   –       •      –    2023-12-15 4 A $2.73 $11,037 D/D 4,043 34,801 0 -
INCY Incyte Corp Director   –       •      –    2020-08-27 4 OE $18.97 $379,400 D/D 20,000 34,243 0 -
BDTX Black Diamond Therapeutic...   –       •      –    2023-09-15 4 A $3.60 $10,750 D/D 2,986 30,758 0 -
INCY Incyte Corp Director   –       •      –    2019-11-08 4 OE $12.46 $513,576 D/D 41,218 30,674 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us